Bi
Non verificato

BioArctic

Di cosa scriviamo

BiologiaEconomiaFarmaceuticaFitnessSanità
29/07/2026
Salute
Fitness
Media
Marketing
Comunicazione
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026
1.00
14/07/2026
Salute
Fitness
Cronaca Rosa / Gossip
Cronaca Bianca
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026
1.00
14/07/2026
Salute
Fitness
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
FDA approves Leqembi Iqlik® (lecanemab-irmb) subcutaneous injection as a starting dose for early Alzheimer's disease
1.00
30/06/2026
Salute
Fitness
Fiere
Eventi
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
New clinical and real-world evidence on Lecanemab to be presented at AAIC conference 2026
1.00
22/06/2026
Salute
Fitness
Imprese
Industria
Medicina - Varie
Scienza
Ecologia/Salute ambientale
Agricoltura
BioArctic and Lilly sign research and collaboration agreement combining Lilly compound with BioArctic's BrainTransporter™ technology
1.00
30/05/2026
Salute
Fitness
Media
Marketing
Comunicazione
Medicina - Varie
Number of shares and votes in BioArctic AB (publ) as of May 29, 2026
1.00
28/05/2026
Salute
Fitness
Media
Marketing
Comunicazione
Medicina - Varie
Bulletin from the Annual General Meeting in BioArctic AB (publ)
1.00
25/05/2026
Salute
Fitness
Media
Marketing
Comunicazione
Medicina - Varie
BioArctic's partner Eisai presents sales simulation of potential future sales of Leqembi® at its Investor Relations Day
1.00
20/05/2026
Salute
Fitness
Economia
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
BioArctic Interim Report for the period January - March 2026
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0